This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date. clinical trials
16 indexed studies · 7 currently recruiting
- CompletedPhase I
Deferred Registration: Quotient Sciences Code: QSC303709
This is an early-stage Phase 1 clinical trial run by Quotient Sciences in the UK. The study is testing the safety of a potential new medicine in healthy male volunteers aged 30 to 65. Specific details about the medicine are temporarily confidential and will be published once initial testing finishes.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Deferred Registration: Quotient Sciences Code: QSC303955
This is an early-stage Phase 1 clinical trial for healthy adults aged 18 to 55. It tests the safety of a new medicine. Detailed information about the drug is currently kept confidential under official UK research rules, but it will be made public once this initial stage finishes.
For: Healthy volunteersUnited Kingdom · England - Not yet recruitingPhase I
Deferred Registration: Quotient Sciences Code: QSC302324
This is an early-stage Phase 1 clinical trial for healthy volunteers, run by Quotient Sciences in the UK. Full details about the study medicine are temporarily withheld under standard UK research rules. The study aims to test how a new treatment behaves safely inside the human body.
For: This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry dateUnited Kingdom · England - RecruitingPhase I
Deferred Registration - Quotient Sciences Code: QSC303945
This is an early-stage Phase 1 clinical trial looking for healthy men aged 30 to 65. It is run by Quotient Sciences to test the safety of a new medicine. The exact drug details are currently kept private under standard UK trial rules and will be published later.
For: Healthy volunteersUnited Kingdom · England - RecruitingPhase I
Deferred registration: Fortrea code: 776181
This is an early-stage clinical trial for healthy volunteers. The full study details are currently deferred, which means the study team has permission to keep specific information private for a limited time. More information about the treatment and rules for joining will be published on the registry once this period ends.
For: This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry dateUnited Kingdom · England - RecruitingPhase I
Deferred registration - Quotient Sciences Code: QSC304026
This is an early-stage Phase 1 clinical trial looking for healthy male volunteers aged 30 to 65. Run by Quotient Sciences, the trial checks the safety of a potential new treatment. Full study details are temporarily withheld under standard registry rules and will be published once this deferral period ends.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
HMR code: 25-018
This is an early-stage Phase 1 research study for healthy adults aged 18 to 65. The study checks how a new medicine is processed by the body and monitors its safety. Full details about the specific drug are currently private under standard trial registration rules and will be released later.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Deferred registration: Quotient Sciences Code: QSC302976
This is an early-stage (Phase 1) clinical trial looking for healthy men aged 30 to 65. The study tests a new medicine to check its safety and see how the body handles it. Detailed scientific information is temporarily withheld under standard registration rules and will be published at a later date.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Deferred registration - Quotient Sciences Code: QSC303684
This is an early-stage Phase 1 clinical trial looking for healthy male volunteers aged 30 to 65. Run by Quotient Sciences, the study checks the safety of a new medicine. Detailed information is currently deferred under standard research rules, but full study details will be released once the deferral period ends.
For: Healthy VolunteersUnited Kingdom · England - RecruitingPhase I
Deferred registration: Quotient Sciences Code: QSC303849
This is an early-stage Phase I clinical trial looking for healthy adult volunteers aged 18 to 55. It is run by Quotient Sciences to test the safety of a new medicine. Full details about the study drug are temporarily kept private under official regulatory rules and will be published soon.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Deferred registration: NRG5051-102
This early-stage Phase 1 trial tests a new drug designed for motor neurone disease, also known as ALS. Researchers are testing it in healthy volunteers aged 25 to 55 to see how well it moves from the blood into the brain, checking basic safety before testing it in patients.
For: Assessment of blood/brain distribution of an IMP for Neurodegenerative Disease, specifically ALS (Amyotrophic Lateral Sclerosis) in healthy adultsUnited Kingdom · England - CompletedPhase I
Deferred registration - Quotient Sciences code: QSC303694
This is an early Phase 1 research study looking for healthy men aged 18 to 65. Its purpose is to check the safety of a new medicine and see how the body handles it. Detailed information about the study medicine is temporarily private while early testing gets under way.
For: Healthy volunteersUnited Kingdom · England - RecruitingPhase I
Deferred registration: HMR code: 25-008
This is an early-stage Phase 1 clinical trial looking for healthy adult volunteers aged 18 to 55. It aims to test a new treatment for safety. Full scientific details are currently withheld under standard UK research rules, but more information will be published as the study moves forward.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Deferred registration: Quotient Sciences Code: QSC304473
This is a Phase 1 clinical trial looking for healthy male volunteers aged between 30 and 65. The study tests how a new medicine behaves in the body and checks for safety. Full scientific details are currently deferred, meaning they will be published online once early testing milestones are met.
For: Healthy volunteersUnited Kingdom · England - Not yet recruitingPhase I
Deferred registration - Phase I trial - Quotient Sciences code: QSC303633
This early-stage study is looking for healthy volunteers aged 18-55. It's a 'Phase 1' trial, which means it's one of the first times a new treatment is tried in people. We're waiting for more details, but it's important for understanding how new medicines work safely.
For: Healthy volunteersUnited Kingdom · England - CompletedPhase I
Deferred registration: Quotient Sciences code: QSC303996
This is an early-stage study (Phase I) for healthy men aged 25 to 55. It's too early to share all the details, but they will be made public soon. This type of study mainly checks the safety of a new treatment.
For: Healthy volunteersUnited Kingdom · England